GRK 2762 - Publications
2025
The effect of Durvalumab consolidation after definitive radiochemotherapy for non-operable stage III NSCLC on the dose effect relation for therapy related pulmonary infiltrates as a risk factor for pneumonitis
Herz A, Guberina, M, Pöttgen C, Gauler T, Ton TTM, Fischedick G, Kiwitt L, Khouya A, Lübcke W, Hoffmann C, Schuler M, Metzenmacher M, Schaarschmidt B, Bos D, Opitz M, Hautzel H, Darwiche K, Bölükbas S h, Grapatsas K h, Gockeln L i, Hetzel M a,i, Mladenov E a, Wirsdörfer F i, Jendrossek V, Stuschke, M, Guberina N. The effect of Durvalumab consolidation after definitive radiochemotherapy for non-operable stage III NSCLC on the dose effect relation for therapy related pulmonary infiltrates as a risk factor for pneumonitis. Transl Lung Cancer accepted. 2025. doi: 10.21037/tlcr-2024-1284.
MetaboDynamics: Bayesian analysis of longitudinal metabolomics data
Danielzik K, Kitanovski S, Matschke J, Hoffmann D. MetaboDynamics: Bayesian analysis of longitudinal metabolomics data. Bioconductor. 2025. doi: 10.18129/B9.bioc.MetaboDynamics.
Matrix-Free Normal Human Epithelial-Fibroblast 3D Spheroid Cultures for In Vitro Lung Modeling
Stasch LM, Buchholzki M, Kitanovski S, Budeus B, Klein D. Matrix-Free Normal Human Epithelial-Fibroblast 3D Spheroid Cultures for In Vitro Lung Modeling. Methods Mol Biol. 2025. doi: 10.1007/7651_2025_622.
ClustIRR: Clustering of immune receptor repertoires
Kitanovski S, Wollek K. ClustIRR: Clustering of immune receptor repertoires. Bioconductor. 2025. doi: 10.18129/B9.bioc.ClustIRR,R package version 1.6.0, doi: 10.18129/B9.bioc.ClustIRR.
Quantitative Visualisierung von HTseq-Daten
Kitanovski S, Wollek K, Hoffmann D. Quantitative Visualisierung von HTseq-Daten. Biospektrum 31, 49–51. 2025. doi: 10.1007/s12268-025-2369-0.
2024
Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer
Dankó B, Hess J, Unger K, Samaga D, Walz C, Walch A, Sun N, Baumeister P, Zeng PYF, Walter F, Marschner S, Späth R, Gires O, Herkommer T, Dazeh R, Matos T, Kreutzer L, Matschke J, Eul K, Klauschen F, Pflugradt U, Canis M, Ganswindt U, Mymryk JS, Wollenberg B, Nichols AC, Belka C, Zitzelsberger H, Lauber K, Selmansberger M. Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer. NPJ Precis Oncol. 2024 May 23;8(1):116. doi: 10.1038/s41698-024-00602-0.